Prescription Opioid Discontinuation: Honoring Patient Insights and Experience to Support Safe and Caring Transitions -- Decision Aid Pilot
Enrolling by invitationNot applicableNCT07202026
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Because of recent policies to decrease opioid use, some people using long-term opioid therapy (LTOT) are encouraged or required to stop (discontinue) taking opioids. That has led experts to be concerned that patients whose LTOT is discontinued could have untreated pain, turn to other substance use and possibly illicit opioids, or have worsened mental health symptoms leading to suicide. To guide safer policies, guidelines, and care, this study will interview patients and doctors about discontinuing LTOT and use the results to develop a patient-centered decision aid (DA) to improve patient-provider communication around discontinuation of LTOT. Once the DA is finalized, it will be pilot tested with a group of 30 patients who are currently on LTOT. The pilot will assess DA implementation feasibility; acceptability; knowledge transfer; and ability to successfully foster positive, patient-centered conversations about opioid discontinuation.
Study details
- Official title
- Patient Perspectives on Prescription Opioid Discontinuation: Understanding and Promoting Safe Transitions
- Conditions
- Opioid Tapering
- Interventions
- Behavioral: Patient-centered Decision Aid to support long-term opioid therapy tapering
- Sponsor
- Kaiser Permanente
- Collaborators
- University of Arkansas; University of Washington
- Start date
- 2025-10-29
- Primary completion
- 2026-03
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
EHR-based inclusion criteria: * age 18 or older * LTOT in the past 18 months (LTOT is ≥60 days of ≥50 MEDs day in each of 2 consecutive 90-day periods with medication treatment for OUD excluded) Inclusion criteria confirmed by participant * Have been taking opioids for chronic pain for at least 6 months * Able to speak and read English EHR-based exclusion criteria: * cancer diagnosis in the last 5 years (excluding non-melanoma skin cancers) * current palliative or hospice care * cognitive disability * psychiatric hospitalization in the last year * surgery in the last 6 months * current residence in an inpatient rehabilitation or skilled nursing facility Exclusion criteria determined by study \- participated in an interview for Aim 1 of this study
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07202026